Home         Forums  

Go Back   Marrowforums > Bone Marrow Failure Diseases > News and Events
Register FAQ Search Today's Posts Mark Forums Read

News and Events News related to bone marrow failure diseases

Reply
 
Thread Tools Search this Thread
  #1  
Old Thu Dec 16, 2010, 02:25 PM
akita akita is offline
Member
 
Join Date: Nov 2010
Posts: 110
ASH 2010 Lenalidomide in MDS with Karyotypes other than del 5q and Refractory to ESAs

http://ash.confex.com/ash/2010/webpr...aper27957.html

4002 Lenalidomide (LEN) In Lower-Risk Myelodysplastic Syndromes (MDS) with Karyotypes Other Than Deletion 5q and Refractory to Erythropoiesis-Stimulating Agents (ESAs)

More than 40 % of the patients in this study became transfusion-independent.

"In lower-risk MDS, anemia is the main therapeutic challenge. ESAs can frequently correct anemia, but not all pts respond and median response duration to ESAs is only about 2 years. LEN yields RBC transfusion-independence (TI) in 65% of lower risk MDS with del(5q)] and about 25% of lower risk MDS without del 5q "

"31 consecutive lower-risk non-del(5q) MDS with anemia refractory to ESAs ( Erythropoiesis-Stimulating Agents) were treated with LEN through a compassionate program."

"LEN yielded RBC transfusion independence in more than 40% of the patients and was well-tolerated. Treatment-induced cytopenia (a possible side-effect, akita) was associated with fewer erythroid responses and shorter response duration."

Last edited by akita : Thu Dec 16, 2010 at 02:55 PM.
Reply With Quote
Reply


Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump


All times are GMT -4. The time now is 12:42 PM.


Powered by vBulletin® Version 3.6.7
Copyright ©2000 - 2018, Jelsoft Enterprises Ltd.
Forum sites may contain non-authoritative and unverified information.
Medical decisions should be made in consultation with qualified medical professionals.
Site contents exclusive of member posts Copyright 2006-2018 Marrowforums.org